Recent advances in breast cancer treatmentISSN: 1465-542X (Online) In this topical collection (7 articles) Review uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies Michael J Duffy, Patricia M McGowan, Nadia Harbeck… Article:428 ...
Persson I, Bergstrom R, Barlow L, Adami HO: Recent trends in breast cancer incidence in Sweden. Br J Cancer 1998, 77(1):167-169.Persson I., Bergstrom R., Barlow L., & Adami H.O. (1998) Recent trends in breast cancer incidence in Sweden. Br.J Cancer 77, 167-169....
Open Access ArticlesResearch Article Increased SLC7A3 Expression Inhibits Tumor Cell Proliferation and Predicts a Favorable Prognosis in Breast CancerPp: 55-70 Volume: 20, Issue: 1 Authors: Lifang He, Yue Xu, Jiediao Lin, Stanley Li Lin* and Yukun Cui* ...
The concept of SGT is based on the killing of cancer cells by introducing a therapeutic gene in the cancer cell. After entry into the cancer cells, these SGTs have been reported to express and kill the cells without correcting the malignant mutations. It has also been shown that these SGTs...
(cytosensor), which captured breast cancer cells (MCF7) with high EpCAM expression by creating three-dimensional bionic interfaces and cross-linking long nanofibers (glycolic acid-lactic acid) (PLGA) to the surface of Ni micropolar using an electrospinning method. Afterwards, through the use of ...
Unprecedented declines in invasive breast cancer rates occurred in the United States between 2001 and 2004, particularly for estrogen receptor-positive tumors among non-Hispanic white women over 50 years. To understand the broader public health import of these reductions among previously unstudied populati...
As our understanding of the biology of breast cancer continues to improve, treatment of the disease continues to change. Although the ultimate goal of treatment remains improved survival, increasing emphasis is now put on less morbid treatments and improving quality of life. Prevention remains a ...
Triple-negative breast cancer (TNBC), a highly aggressive subtype of breast cancer, negatively expresses estrogen receptor, progesterone receptor, and the human epidermal growth factor receptor 2 (HER2). Although chemotherapy is the main form of treatment for patients with TNBC, the effectiveness of ...
nearly 19.3 million new cancer cases and approximately 10 million cancer-related deaths are expected by 2020. The five most commonly diagnosed cancers are female breast cancer (11.7%), lung cancer (11.4%), colorectal cancer (10%), prostate cancer (PC; 7.3%), and stomach cancer (5.6%) [2...
To review recent developments in hormonal therapy for metastatic breast cancer. Published books and articles Newer hormonal agents are offering women alternatives for sequential therapy of metastatic disease that provide benefit with less risk. A thorough understanding of the relationship between hormonal in...